A citation-based method for searching scientific literature

G Savulich, R Riccelli, L Passamonti, M Correia, J F W Deakin, R Elliott, R S A Flechais, A R Lingford-Hughes, J McGonigle, A Murphy, D J Nutt, C Orban, L M Paterson, L J Reed, D G Smith, J Suckling, R Tait, E M Taylor, B J Sahakian, T W Robbins, K D Ersche. Transl Psychiatry 2017
Times Cited: 14







List of co-cited articles
83 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task.
Liam J Nestor, Anna Murphy, John McGonigle, Csaba Orban, Laurence Reed, Eleanor Taylor, Remy Flechais, Louise M Paterson, Dana Smith, Edward T Bullmore,[...]. Addict Biol 2017
14
28

Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Joseph P Schacht, Raymond F Anton, Konstantin E Voronin, Patrick K Randall, Xingbao Li, Scott Henderson, Hugh Myrick. Neuropsychopharmacology 2013
63
28

Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.
Hugh Myrick, Raymond F Anton, Xingbao Li, Scott Henderson, Patrick K Randall, Konstantin Voronin. Arch Gen Psychiatry 2008
175
28

Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.
Primavera A Spagnolo, Vijay A Ramchandani, Melanie L Schwandt, Lishu Zhang, Sara K Blaine, Julie M Usala, Kristie A Diamond, Monte J Phillips, David T George, Reza Momenan,[...]. Alcohol Clin Exp Res 2014
19
28

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
Joseph P Schacht, Patrick K Randall, Patricia K Latham, Konstantin E Voronin, Sarah W Book, Hugh Myrick, Raymond F Anton. Neuropsychopharmacology 2017
51
28

Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals.
Laurel S Morris, Kwangyeol Baek, Roger Tait, Rebecca Elliott, Karen D Ersche, Remy Flechais, John McGonigle, Anna Murphy, Liam J Nestor, Csaba Orban,[...]. Addict Biol 2018
17
21

Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.
Karl Mann, Sabine Vollstädt-Klein, Iris Reinhard, Tagrid Leménager, Mira Fauth-Bühler, Derik Hermann, Sabine Hoffmann, Ulrich S Zimmermann, Falk Kiefer, Andreas Heinz,[...]. Alcohol Clin Exp Res 2014
60
21

Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?
G Rubio, G Ponce, R Rodriguez-Jiménez, M A Jiménez-Arriero, J Hoenicka, T Palomo. Alcohol Alcohol 2005
68
21

Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study.
Scott E Lukas, Steven B Lowen, Kimberly P Lindsey, Nina Conn, Wendy Tartarini, John Rodolico, Gopi Mallya, Christopher Palmer, David M Penetar. Neuroimage 2013
52
21

Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
Lara A Ray, Pauline F Chin, Karen Miotto. CNS Neurol Disord Drug Targets 2010
73
21

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
Stephanie S O'Malley, Suchitra Krishnan-Sarin, Conor Farren, Rajita Sinha, Mary Jeanne Kreek. Psychopharmacology (Berl) 2002
356
21

Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.
James C Garbutt, Amy M Greenblatt, Suzanne L West, Laura C Morgan, Alexei Kampov-Polevoy, Harmon S Jordan, Georgiy V Bobashev. Addiction 2014
55
21

Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.
Christian S Hendershot, Jeffrey D Wardell, Andriy V Samokhvalov, Jürgen Rehm. Addict Biol 2017
41
21

Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study.
Darren R Quelch, Inge Mick, John McGonigle, Anna C Ramos, Remy S A Flechais, Mark Bolstridge, Eugenii Rabiner, Matthew B Wall, Rexford D Newbould, Björn Steiniger-Brach,[...]. Biol Psychiatry 2017
21
21

Effects of buprenorphine on responses to social stimuli in healthy adults.
Anya K Bershad, Jacob A Seiden, Harriet de Wit. Psychoneuroendocrinology 2016
31
21

Impaired response inhibition function in abstinent heroin dependents: an fMRI study.
Li-ping Fu, Guo-hua Bi, Zhi-tong Zou, Yan Wang, En-mao Ye, Lin Ma, Ming-Fan, Zheng Yang. Neurosci Lett 2008
110
14

The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
Louise M Paterson, Remy S A Flechais, Anna Murphy, Laurence J Reed, Sanja Abbott, Venkataramana Boyapati, Rebecca Elliott, David Erritzoe, Karen D Ersche, Yetunde Faluyi,[...]. J Psychopharmacol 2015
17
14

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D V Sheehan, Y Lecrubier, K H Sheehan, P Amorim, J Janavs, E Weiller, T Hergueta, R Baker, G C Dunbar. J Clin Psychiatry 1998
14

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.
Jon-Kar Zubieta, Joshua A Bueller, Lisa R Jackson, David J Scott, Yanjun Xu, Robert A Koeppe, Thomas E Nichols, Christian S Stohler. J Neurosci 2005
507
14

Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network.
Charlotte A Boettiger, Elizabeth A Kelley, Jennifer M Mitchell, Mark D'Esposito, Howard L Fields. Pharmacol Biochem Behav 2009
53
14

Factor structure of the Barratt impulsiveness scale.
J H Patton, M S Stanford, E S Barratt. J Clin Psychol 1995
14

Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
Lara A Ray, Kelly E Courtney, Dara G Ghahremani, Karen Miotto, Arthur Brody, Edythe D London. Am J Drug Alcohol Abuse 2015
25
14

The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.
Kelly E Courtney, Dara G Ghahremani, Lara A Ray. Neuropsychopharmacology 2016
15
14

The declining efficacy of naltrexone pharmacotherapy for alcohol use disorders over time: a multivariate meta-analysis.
A C Del Re, Natalya Maisel, Janet Blodgett, John Finney. Alcohol Clin Exp Res 2013
18
14

Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
Suchitra Krishnan-Sarin, John H Krystal, Julia Shi, Brian Pittman, Stephanie S O'Malley. Biol Psychiatry 2007
81
14

Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans.
Julian C Motzkin, Carissa L Philippi, Richard C Wolf, Mustafa K Baskaya, Michael Koenigs. Biol Psychiatry 2015
192
14

Non-specific effect of naltrexone on ethanol consumption in social drinkers.
H de Wit, J Svenson, A York. Psychopharmacology (Berl) 1999
39
14

Effects of naltrexone during the descending limb of the blood alcohol curve.
Lara A Ray, Kent E Hutchison, James MacKillop, Robert Miranda, Amy Audette, Robert Swift, Peter M Monti. Am J Addict 2008
20
14

The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype.
Elaine Setiawan, Robert O Pihl, Sylvia M L Cox, Christina Gianoulakis, Roberta M Palmour, Chawki Benkelfat, Marco Leyton. Alcohol Clin Exp Res 2011
48
14

Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking.
Amy W Helstrom, Frederick C Blow, Valerie Slaymaker, Henry R Kranzler, Shirley Leong, David Oslin. Alcohol Alcohol 2016
12
16

Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.
Antonio-Javier Chamorro, Miguel Marcos, José-Antonio Mirón-Canelo, Isabel Pastor, Rogelio González-Sarmiento, Francisco-Javier Laso. Addict Biol 2012
108
14

Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
Natalya C Maisel, Janet C Blodgett, Paula L Wilbourne, Keith Humphreys, John W Finney. Addiction 2013
198
14

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
Daniel E Jonas, Halle R Amick, Cynthia Feltner, Georgiy Bobashev, Kathleen Thomas, Roberta Wines, Mimi M Kim, Ellen Shanahan, C Elizabeth Gass, Cassandra J Rowe,[...]. JAMA 2014
424
14

A genetic determinant of the striatal dopamine response to alcohol in men.
V A Ramchandani, J Umhau, F J Pavon, V Ruiz-Velasco, W Margas, H Sun, R Damadzic, R Eskay, M Schoor, A Thorsell,[...]. Mol Psychiatry 2011
214
14

Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.
Lara A Ray, Spencer Bujarski, Pauline F Chin, Karen Miotto. Neuropsychopharmacology 2012
54
14

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.
Elise M Weerts, Yu Kyeong Kim, Gary S Wand, Robert F Dannals, Jae Sung Lee, J James Frost, Mary E McCaul. Neuropsychopharmacology 2008
92
14

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Raymond F Anton, Stephanie S O'Malley, Domenic A Ciraulo, Ron A Cisler, David Couper, Dennis M Donovan, David R Gastfriend, James D Hosking, Bankole A Johnson, Joseph S LoCastro,[...]. JAMA 2006
14

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III.
Bridget F Grant, Risë B Goldstein, Tulshi D Saha, S Patricia Chou, Jeesun Jung, Haitao Zhang, Roger P Pickering, W June Ruan, Sharon M Smith, Boji Huang,[...]. JAMA Psychiatry 2015
14

Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?
Lara A Ray, Spencer Bujarski, Megan M Yardley, Daniel J O Roche, Emily E Hartwell. Am J Drug Alcohol Abuse 2017
41
14

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
Kim Donoghue, Catherine Elzerbi, Rob Saunders, Craig Whittington, Stephen Pilling, Colin Drummond. Addiction 2015
54
14

Differences Between Treatment-Seeking and Nontreatment-Seeking Alcohol-Dependent Research Participants: An Exploratory Analysis.
Matthew C H Rohn, Mary R Lee, Samuel B Kleuter, Melanie L Schwandt, Daniel E Falk, Lorenzo Leggio. Alcohol Clin Exp Res 2017
36
14

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.
Lara A Ray, Christina S Barr, Julie A Blendy, David Oslin, David Goldman, Raymond F Anton. Alcohol Clin Exp Res 2012
62
14

Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
Raymond F Anton, Konstantin K Voronin, Patrick K Randall, Hugh Myrick, Abraham Tiffany. Alcohol Clin Exp Res 2012
50
14

Neural substrates of cue reactivity: association with treatment outcomes and relapse.
Kelly E Courtney, Joseph P Schacht, Kent Hutchison, Daniel J O Roche, Lara A Ray. Addict Biol 2016
108
14

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).
J T Sullivan, K Sykora, J Schneiderman, C A Naranjo, E M Sellers. Br J Addict 1989
14

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
Joseph P Schacht, Patrick K Randall, Patricia K Latham, Konstantin E Voronin, Sarah W Book, Hugh Myrick, Raymond F Anton. Neuropsychopharmacology 2017
7
28



Direct and indirect associations between perception of childhood trauma and suicidal ideation through emotion dysregulation in males who use heroin.
Ali Mohammadzadeh, Zahra Ganji, Vahid Khosravani, Azra Mohammadpanah Ardakan, Ali Amirinezhad. Addict Behav 2019
8
25

Exposure to Childhood Abuse and Later Substance Use: Indirect Effects of Emotion Dysregulation and Exposure to Trauma.
Amar Mandavia, Gabriella G N Robinson, Bekh Bradley, Kerry J Ressler, Abigail Powers. J Trauma Stress 2016
38
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.